niacinamide has been researched along with coenzyme q10 in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (8.33) | 18.7374 |
1990's | 5 (41.67) | 18.2507 |
2000's | 3 (25.00) | 29.6817 |
2010's | 1 (8.33) | 24.3611 |
2020's | 2 (16.67) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Geshi, E; Hiroshige, J; Katagiri, T; Konno, N; Mochizuki, M; Umetsu, K | 1 |
Beal, MF; Henshaw, DR; Matthews, RT; Schulz, JB | 2 |
Beal, MF | 2 |
Beal, MF; Henshaw, DR; Jenkins, BG; Rosen, BR; Schulz, JB | 1 |
Beal, MF; Fallon, J; Hyman, BT; Matthews, RT | 1 |
Driver, C; Georgiou, A | 1 |
Carcassi, AM; Collu, M; Licheri, D; Littarru, GP; Mancinelli, R; Naimi, S; Vargiu, R | 1 |
Brüggemann, N; Dobricic, V; Dulovic-Mahlow, M; Imhoff, S; Kandaswamy, KK; Klein, C; Lohmann, K; Münchau, A; Nolte, A; Rolfs, A; Schäfer, J; Tadic, V; Trinh, J; Werber, M | 1 |
Agnifili, L; Aloia, R; Brescia, L; Ferrante, C; Figus, M; Mastropasqua, L; Orlando, G; Rossi, GCM; Sacchi, M | 1 |
2 review(s) available for niacinamide and coenzyme q10
Article | Year |
---|---|
Neurochemistry and toxin models in Huntington's disease.
Topics: Animals; Coenzymes; Disease Models, Animal; Energy Metabolism; Humans; Huntington Disease; Mitochondria; Neurotoxins; Niacinamide; Nitro Compounds; Propionates; Ubiquinone | 1994 |
Bioenergetic approaches for neuroprotection in Parkinson's disease.
Topics: Acetylcarnitine; Coenzymes; Creatine; Energy Metabolism; Free Radicals; Ginkgo biloba; Humans; Mitochondria; Neuroprotective Agents; Niacinamide; Nootropic Agents; Parkinson Disease; Phytotherapy; Thioctic Acid; Ubiquinone | 2003 |
10 other study(ies) available for niacinamide and coenzyme q10
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Protection of acute ischemic myocardial injury by pharmacological intervention.
Topics: Adenosine Triphosphatases; Adrenergic alpha-Antagonists; Animals; Calcium; Calcium-Transporting ATPases; Coenzymes; Coronary Disease; Diltiazem; Dogs; Myocardium; Niacinamide; Nicorandil; Quinazolines; Sarcoplasmic Reticulum; Ubiquinone; Vasodilator Agents | 1989 |
Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity.
Topics: Animals; Benzenesulfonates; Coenzymes; Corpus Striatum; Free Radicals; Male; Mice; Mice, Inbred Strains; MPTP Poisoning; Neuroprotective Agents; Niacinamide; Spin Labels; Ubiquinone | 1995 |
Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate.
Topics: Animals; Coenzymes; Corpus Striatum; Dose-Response Relationship, Drug; Magnetic Resonance Imaging; Male; Malonates; Mitochondria; Niacinamide; Rats; Rats, Sprague-Dawley; Ubiquinone | 1994 |
Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Anticonvulsants; Coenzymes; Cyclic N-Oxides; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Free Radicals; Lamotrigine; Male; Malonates; Memantine; Mitochondria; Nervous System Diseases; Neuroprotective Agents; Neurotoxins; Niacinamide; Nitro Compounds; Nitrogen Oxides; Propionates; Pyrimidines; Rats; Rats, Sprague-Dawley; Spin Labels; Thallium; Triazines; Ubiquinone | 1996 |
MPP+ produces progressive neuronal degeneration which is mediated by oxidative stress.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Coenzymes; Cyclic N-Oxides; Dopamine Agents; Drug Combinations; Ions; Male; Nerve Degeneration; Niacinamide; Nitrogen Oxides; Oxidative Stress; Rats; Rats, Sprague-Dawley; Spin Labels; Substantia Nigra; Time Factors; Ubiquinone | 1997 |
How to re-energise old mitochondria without shooting yourself in the foot.
Topics: Animals; Coenzymes; DNA, Mitochondrial; Drosophila; Energy Metabolism; Longevity; Mitochondria; Niacinamide; Reactive Oxygen Species; Ubiquinone | 2002 |
Enhancement of muscular performance by a coformulation of propionyl-L-carnitine, coenzyme Q10, nicotinamide, riboflavin and pantothenic acid in the rat.
Topics: Animals; Antioxidants; Blood Pressure; Body Weight; Carnitine; Coenzymes; Drug Combinations; Energy Metabolism; Female; Heart; Heart Rate; Male; Motor Activity; Muscle, Skeletal; Muscle, Smooth; Niacinamide; Organ Size; Pantothenic Acid; Papillary Muscles; Rats; Rats, Wistar; Riboflavin; Sex Characteristics; Ubiquinone | 2002 |
Novel NAXE variants as a cause for neurometabolic disorder: implications for treatment.
Topics: Brain Diseases, Metabolic, Inborn; Female; Humans; Male; Mutation, Missense; Neurodevelopmental Disorders; Niacinamide; Pedigree; Racemases and Epimerases; Ubiquinone; Young Adult | 2020 |
Citicoline/Coenzyme Q10/Vitamin B3 Fixed Combination Exerts Synergistic Protective Effects on Neuronal Cells Exposed to Oxidative Stress.
Topics: Brain-Derived Neurotrophic Factor; Cytidine Diphosphate Choline; Dopamine; Humans; Inflammation; Interleukin-6; Niacinamide; Oxidative Stress; Tumor Necrosis Factor-alpha; Ubiquinone | 2022 |